ArticleScientific reports2021

Greater reductions in blood flow after anti-angiogenic treatment in non-small cell lung cancer patients are associated with shorter progression-free survival.

Daisuke Katayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.